Uncategorised - European Medical Journal

AI assisted skin analysis on a smartphone for intelligent psoriasis research and digital dermatology.

Intelligent Psoriasis Research Suggests New Care Model

Intelligent psoriasis research is accelerating precision diagnosis, personalized treatment, and long term management across dermatology.

Physician discussing nutrition and scurvy risk with adult patient in clinical consultation.

Scurvy Linked to Unusual Joint Bleeding

Scurvy can present with hemarthrosis and musculoskeletal symptoms that closely mimic inflammatory rheumatologic disease.

NHS App to Launch New AI Triage Tool

The NHS App is set to launch a new AI triage tool, designed to cut waiting times and improve patient care.

IVF add-ons

Evidence Behind IVF Add-Ons Deemed Insubstantial and Poor

New research has found that evidence behind the effectiveness of IVF treatment add-ons is poor.

EHA Lifetime Achievement 2026 Awardee: Claire Harrison

Before the advent of JAK inhibitors, we did not have any effective therapy for patients with myelofibrosis. We could offer them a…

Haleon enters five-year AI pact with Microsoft

Haleon has partnered with Microsoft in a new five-year collaboration to scale AI capabilities across the business.

systemic lupus erythematosus

Anifrolumab Shows Real-World Promise in Systemic Lupus Erythematosus

New real-world data show anifrolumab reduces disease activity and calms interferon-driven immune signals in active systemic lupus erythematosus.

rosacea

Ivermectin, E-BPO Outperform Metronidazole in Rosacea

A network meta-analysis found topical ivermectin and encapsulated benzoyl peroxide were more effective than metronidazole for moderate-to-severe rosacea.

diet dementia

Healthy Diet May Delay Dementia Even with Alzheimer's Pathology

New research finds diet quality is tied to lower dementia risk even in people with Alzheimer’s pathology, with anti-inflammatory eating standing out.

Immunosuppressants Raise Mortality Risk in Pulmonary Mucormycosis

Study identifies immunosuppressant use and solid organ transplantation as key risk factors for mortality in patients with pulmonary mucormycosis and non-hematologic malignancies.